glp-1 and rheumatoid arthritis Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling GLP-1 agonists' potential effects on

Using some naive assumptions here (that the average weight loss required for the average obese persons BMI to be below 30 and thus not categorized as obese, assuming x% of obese people take the drug and all experience the average reduction in body weight), we can see a picture emerge that shows the potential to disrupt a trend thats been forming for the past 50 years

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease

Bush Institute for Womens Health at Texas Tech University Health Sciences Center grant 16OCT2023

Protein-first approach: Minimum 0.7-1.0g protein per pound of body weight daily

Understand customers based on end user analysis

There are notable differences between the two